PMNT(PMNT)
PMNT
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $27M | $29M |
| Low | $27M | $29M |
| High | $27M | $29M |
| EBITDA Avg | $-11M | $-12M |
| Low | $-11M | $-12M |
| High | $-11M | $-12M |
| EBIT Avg | $-12M | $-13M |
| Low | $-12M | $-13M |
| High | $-12M | $-13M |
| Net Income Avg | $-2M | $-1M |
| Low | $-2M | $-1M |
| High | $-2M | $-1M |
| EPS Avg | $-0.05 | $-0.04 |
| Low | $-0.05 | $-0.04 |
| High | $-0.05 | $-0.04 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $6M | $14M | $6M | $2M | $6M | $16M | $7M |
| Low | $6M | $14M | $6M | $2M | $6M | $16M | $7M |
| High | $6M | $14M | $6M | $2M | $6M | $16M | $7M |
| EBITDA Avg | $-2M | $-6M | $-3M | $-632,010 | $-3M | $-7M | $-3M |
| Low | $-2M | $-6M | $-3M | $-632,010 | $-3M | $-7M | $-3M |
| High | $-2M | $-6M | $-3M | $-632,010 | $-3M | $-7M | $-3M |
| EBIT Avg | $-2M | $-6M | $-3M | $-661,930 | $-3M | $-7M | $-3M |
| Low | $-2M | $-6M | $-3M | $-661,930 | $-3M | $-7M | $-3M |
| High | $-2M | $-6M | $-3M | $-661,930 | $-3M | $-7M | $-3M |
| Net Income Avg | $-506,171 | $2M | $-1M | — | — | — | — |
| Low | $-506,171 | $2M | $-1M | — | — | — | — |
| High | $-506,171 | $2M | $-1M | — | — | — | — |
| EPS Avg | $-0.01 | $0.04 | $-0.02 | — | — | — | — |
| Low | $-0.01 | $0.04 | $-0.02 | — | — | — | — |
| High | $-0.01 | $0.04 | $-0.02 | — | — | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |